CONTACT INFORMATION http://www.loyola.org
Robert Mittendorf
M.D.,Dr.P.H., FACOG
  • Professor Emeritus
  • General Obstetrics and Gynecology
Specialties
Premature Labor
Board Certifications
  • Obstetrics & Gynecology - General Cert: AM Board of Obstetrics/Gynecology
Publications

Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality?Pryde,Peter, G.; Mittendorf,RobertJournal of perinatal medicine 2011 ;39(4):375-378

Authors' Reply: Contemporary Usage of Obstetric Magnesium Sulfate: Indication, Contraindication, and Relevance of DosePryde,P. G.; Mittendorf,R.Obstetrics & Gynecology 2010 ;115(1):186

Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dosePryde,P. G.; Mittendorf,R.Obstetrics & Gynecology 2009 ;114(3):669-673

Magnesium sulfate for the prevention of cerebral palsy.Mittendorf,R.; Pryde,P. G.New England Journal of Medicine 2009 ;360(2):189-190

Relationships between umbilical cord arterial blood pH levels at delivery and Bayley Psychomotor Development Index scores in early childhood.Mittendorf,R.; Won,S. Y.; Gianopoulos,J. G.; Pryde,P. G.; Roizen,N.Journal of perinatal medicine 2008 ;36(4):335-340

Magnesium sulfate tocolysis: time to quitMittendorf,R.Obstetrics & Gynecology 2007 ;109(5):1204-1205

Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm laborMittendorf,R.; Dammann,O.; Lee,K. S.Journal of Perinatology 2006 ;26(1):57-63

Neuroprophylaxis with aminophylline and magnesium sulfate?[comment].Mittendorf,R.; Pyrde,P. G.American Journal of Obstetrics & Gynecology 2006 ;194(2):593

A review of the role for magnesium sulphate in preterm labourMittendorf,R.; Pryde,P. G.BJOG: An International Journal of Obstetrics & Gynaecology 2005 ;112(Suppl 1):84-88

Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates.Mittendorf,R.; Kuban,K.; Pryde,P. G.; Gianopoulos,J. G.; Yousefzadeh,D.Journal of Perinatology 2005 ;25(2):101-107

Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates.Mittendorf,R.; Covert,R.; Montag,A. G.; elMasri,W.; Muraskas,J.; Lee,K. S.; Pryde,P. G.Journal of perinatal medicine 2005 ;33(5):428-434

Risk-benefit effects of tocolytic therapyPryde,P. G.; Janeczek,S.; Mittendorf,R.Expert Opinion on Drug Safety 2004 ;3(6):639-654

Association between lenticulostriate vasculopathy (LSV) and neonatal intraventricular hemorrhage (IVH).Mittendorf,R.; Covert,R.; Pryde,P. G.; Lee,K. S.; Ben-Ami,T.; Yousefzadeh,D.Journal of Perinatology 2004 ;24(11):700-705

Magnesium sulfate for preterm neuroprotectionMittendorf,R.; Lee,K. S.; Roizen,N. J.; Pryde,P. G.JAMA 2004 ;291(8):940-941

Second overview of relationships between antenatal pharmacologic magnesium sulfate and neurologic outcomes in childrenMittendorf,R.; Pryde,P. G.; Roizen,N.Journal of perinatal medicine 2004 ;32(3):201-210

The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.Mittendorf,R.; Roizen,N. J.; Pryde,P. G.Journal of Perinatology 2004 ;24(7):465-466

Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children.Mittendorf,R.; Montag,A. G.; MacMillan,W.; Janeczek,S.; Pryde,P. G.; Besinger,R. E.; Gianopoulos,J. G.; Roizen,N.American Journal of Obstetrics & Gynecology 2003 ;188(6):1438-1434

Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infantsMittendorf,R.; Pryde,P. G.; Lee,K. S.American Journal of Obstetrics & Gynecology 2003 ;189(2):613

Education
Medical School
  • University of Kentucky College of Medicine
Residency
  • Tufts University Affiliated Hospitals, Obstetrics & Gynecology
Languages
  • German-not fluent
Interests
  • Travel